ADVM — Adverum Biotechnologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Adverum Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	430	305	186	96.5	126
Net Total Receivables	—	5.71	0	—	—
Prepaid Expenses
Total Current Assets	434	317	191	103	131
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	47.1	119	114	49.8	45.2
Long Term Notes Receivable
Other Long Term Assets
Total Assets	483	440	308	156	180
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	20.9	21.3	32.2	20	22.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48.2	124	127	88.5	109
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	434	316	182	67.2	70.7
Total Liabilities & Shareholders' Equity	483	440	308	156	180
Total Common Shares Outstanding